Onesource Specialty Pharma Ltd Share Price

Overview

Onesource Specialty Pharma Ltd share price is currently ₹1,495.21, down by - ₹22.66 (1.49%) from its previous closing price of ₹1,517.87. The share price has declined -9.99% over the past month and declined -24.25% over the past year. The stock's 52-week low and high are ₹1,042.40 and ₹1,921.90, respectively. Onesource Specialty Pharma Ltd has a market capitalisation of ₹ 17,600.00 Cr. The share price was last updated on 25 Aug 2026, 03:57 PM IST.

Onesource Specialty Pharma Ltd
Onesource Specialty Pharma Ltd
ONESOURCE
 0.00
- 22.66
1.49%
Healthcare
 0.00(%)1D

Updated: 25 Aug 2026, 03:57:28 pm IST

Market Data

Open Price

 1,510.94

Prev. Close

 1,517.87
 1,490.06

Day Low

 1,515.45

Day High

 1,042.40

52 Week Low

 1,921.90

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-352.64

Sector PE

42.03

PB Ratio

2.92

Sector PB

5.83

EPS

-4.24

Dividend Yield

0.00

Today's Volume

60.021 K

5 Day Avg. Volume

67.091 K

PEG Ratio

-3.58

Market Cap.

₹ 17,600.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
Motilal Oswal Large & Midcap Fund - Regular Plan - Growth39.17 Lac
38.22 Lac
(2.44%)
Motilal Oswal Flexi Cap Fund - Regular Plan - Growth23.11 Lac
23.91 Lac
(3.46%)
Motilal Oswal ELSS Tax Saver Fund - Regular Plan - Growth12.21 Lac
10.90 Lac
(10.75%)
360 ONE Focused Fund - Regular Plan - Growth7.77 Lac
10.58 Lac
(36.1%)
Axis Small Cap Fund - Regular Plan - Growth9.17 Lac
9.17 Lac
no change

About Onesource Specialty Pharma Ltd 👋

OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

Frequently Asked Questions

What is the share price of Onesource Specialty Pharma Ltd?

What is the market cap of Onesource Specialty Pharma Ltd?

Should I buy Onesource Specialty Pharma Ltd stock now?

What is the 52 week high and low of Onesource Specialty Pharma Ltd?

Is the Onesource Specialty Pharma Ltd stock good to buy?

Is Onesource Specialty Pharma Ltd a good buy for the long term?

Is Onesource Specialty Pharma Ltd overvalued or undervalued?

What is the PE and PB ratio of Onesource Specialty Pharma Ltd?

Start Now